Jinling Pharmaceutical Company Limited is principally engaged in the manufacture and sale of traditional Chinese and western medical materials, as well as the research, production, technical services and development of new medical products. The Company mainly provides Mailuoning series, buflomedil hydrochloride injections, Shuangxiang Paishi granules, ferrous succinate tablets, Weide'an capsules, lentinan injections, Jinluoring gels and absorbable gelatin sponge, among others. The Company distributes its products mainly in domestic markets. As of December 31, 2009, the Company had 12 subsidiaries.